US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Evommune

6.92

-0.2900-4.02%

Post-market: 6.960.0400+0.58%17:51 EDT

Volume:1.75M

Turnover:12.04M

Market Cap:251.14M

PE:-2.65

High:7.28

Open:7.25

Low:6.74

Close:7.21

52wk High:33.20

52wk Low:6.74

Shares:36.29M

Float Shares:19.98M

Volume Ratio:2.05

T/O Rate:8.73%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.6090

EPS(LYR):-11.2228

ROE:-52.11%

ROA:-31.99%

PB:0.90

PE(LYR):-0.62

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

US Stocks on the MOVE-Cardinal Health, nVent, Acuity

Evommune Gains After Eczema Drug Meets Mid-Stage Trial Goal

Evommune presents Phase 2a PoC data on EVO301 at EADV Congress

Evommune Says Phase 2a Trial Shows Evo301 Cuts EASI 55% at Week 12 in Atopic Dermatitis

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/EVMN"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"EVMN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EVMN\",,,,,undefined,":{"symbol":"EVMN","market":"US","secType":"STK","nameCN":"Evommune","latestPrice":6.92,"timestamp":1790971200000,"preClose":7.21,"halted":0,"volume":1745423,"hourTrading":{"tag":"盘后","latestPrice":6.96,"preClose":6.92,"latestTime":"17:51 EDT","volume":1361,"amount":9469.079923,"timestamp":1790977917791,"change":0.04,"changeRate":0.00578,"amplitude":0.007225},"delay":0,"changeRate":-0.04022191400832178,"floatShares":19982000,"shares":36292113,"eps":-2.609,"marketStatus":"Post-Mkt","change":-0.29,"latestTime":"10-02 18:26:00 EDT","open":7.25,"high":7.28,"low":6.74,"amount":12043238.921431,"amplitude":0.074896,"askPrice":7.56,"askSize":100,"bidPrice":6.07,"bidSize":10,"shortable":0,"etf":0,"ttmEps":-2.609,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1790985600000},"marketStatusCode":4,"adr":0,"listingDate":1762405200000,"exchange":"NYSE","adjPreClose":7.21,"preHourTrading":{"tag":"盘前","latestPrice":7.02,"preClose":7.21,"latestTime":"09:15 EDT","volume":942,"amount":6587.562372,"timestamp":1790946940212,"change":-0.19,"changeRate":-0.026352,"amplitude":0.009709},"postHourTrading":{"tag":"盘后","latestPrice":6.96,"preClose":6.92,"latestTime":"17:51 EDT","volume":1361,"amount":9469.079923,"timestamp":1790977917791,"change":0.04,"changeRate":0.00578,"amplitude":0.007225},"volumeRatio":2.048711,"impliedVol":0.5399,"impliedVolPercentile":0.0885},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EVMN\",,,,,undefined,":{"symbol":"EVMN","floatShares":19982000,"roa":"-31.99%","roe":"-52.11%","lyrEps":-11.222761,"volumeRatio":2.048711,"shares":36292113,"dividePrice":0,"high":7.28,"amplitude":0.074896,"preClose":7.21,"low":6.74,"week52Low":6.74,"pbRate":"0.90","psRate":"25.11","week52High":33.2,"institutionHeld":0,"latestPrice":6.92,"committee":-0.818182,"eps":-2.609,"divideRate":0,"volume":1745423,"delay":0,"ttmEps":-2.609,"open":7.25,"prevYearClose":17.12,"prevWeekClose":8.49,"prevMonthClose":8.26,"prevQuarterClose":8.26,"fiveDayClose":8.49,"twentyDayClose":12,"sixtyDayClose":13.51},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/EVMN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-06","symbol":"EVMN","fiscalQuarterEnding":"2026/06","expectedEps":-0.68,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1785988800000,"reportTimeType":"post","actualEps":-0.89},{"market":"US","date":"2026-05-07","symbol":"EVMN","fiscalQuarterEnding":"2026/03","expectedEps":-0.83,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778126400000,"reportTimeType":"post","actualEps":-0.64},{"market":"US","date":"2026-03-05","symbol":"EVMN","fiscalQuarterEnding":"2025/12","expectedEps":-0.82,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1772686800000,"reportTimeType":"post","actualEps":-1.43}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"EVMN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"EVMN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0.5833,"hold":0.1667,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5833,"analysts":12,"updateTime":1787803200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/EVMN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"EVMN","date":"2026-10-01","current":-2.652357,"percent":1,"low":-16.229076,"twenty":-12.303359,"median":-9.479385,"eighty":-5.516493,"high":-3.16657,"avg":-9.281325,"sd":3.229597,"marketCap":299772853},"quantilePoints":[{"date":"2025-11-07","current":-9.395174,"twenty":-7.823584,"median":-7.430686,"eighty":-7.430686,"marketCap":608469038},{"date":"2025-11-14","current":-8.461694,"twenty":-9.04686,"median":-8.505813,"eighty":-7.430686,"marketCap":548013143},{"date":"2025-11-21","current":-8.689259,"twenty":-9.04686,"median":-8.689259,"eighty":-7.430686,"marketCap":562751147},{"date":"2025-11-28","current":-9.618094,"twenty":-9.051504,"median":-8.707835,"eighty":-8.049291,"marketCap":622906267},{"date":"2025-12-05","current":-10.184684,"twenty":-9.618094,"median":-8.986487,"eighty":-8.483986,"marketCap":659600890},{"date":"2025-12-12","current":-9.657505,"twenty":-9.633858,"median":-9.000419,"eighty":-8.483986,"marketCap":592227156},{"date":"2025-12-19","current":-7.716136,"twenty":-9.618094,"median":-8.986487,"eighty":-8.244704,"marketCap":473176635},{"date":"2025-12-26","current":-9.042428,"twenty":-9.528926,"median":-9.016673,"eighty":-8.355807,"marketCap":554508795},{"date":"2026-01-02","current":-8.800817,"twenty":-9.392482,"median":-9.003431,"eighty":-8.469125,"marketCap":539692472},{"date":"2026-01-09","current":-9.37143,"twenty":-9.380689,"median":-8.972554,"eighty":-8.293747,"marketCap":574684215},{"date":"2026-01-16","current":-10.075701,"twenty":-9.649623,"median":-9.019686,"eighty":-8.354639,"marketCap":617872222},{"date":"2026-01-23","current":-9.710714,"twenty":-9.690151,"median":-9.037572,"eighty":-8.461694,"marketCap":595490116},{"date":"2026-01-30","current":-11.129537,"twenty":-9.775997,"median":-9.042428,"eighty":-8.498847,"marketCap":682496613},{"date":"2026-02-06","current":-8.564346,"twenty":-9.775997,"median":-9.064213,"eighty":-8.549933,"marketCap":525191389},{"date":"2026-02-13","current":-14.332171,"twenty":-9.885497,"median":-9.065437,"eighty":-8.563866,"marketCap":878891712},{"date":"2026-02-20","current":-14.769127,"twenty":-10.094711,"median":-9.253195,"eighty":-8.56425,"marketCap":905687191},{"date":"2026-02-27","current":-13.689588,"twenty":-10.579486,"median":-9.338016,"eighty":-8.621921,"marketCap":839486596},{"date":"2026-03-06","current":-11.484529,"twenty":-11.200535,"median":-9.381712,"eighty":-8.67867,"marketCap":790939493},{"date":"2026-03-13","current":-12.018327,"twenty":-12.245567,"median":-9.479385,"eighty":-8.689259,"marketCap":827702188},{"date":"2026-03-20","current":-12.321662,"twenty":-12.396972,"median":-9.618094,"eighty":-8.70412,"marketCap":848592844},{"date":"2026-03-27","current":-12.379191,"twenty":-12.362455,"median":-9.695292,"eighty":-8.728757,"marketCap":852554865},{"date":"2026-04-02","current":-11.725452,"twenty":-12.336306,"median":-9.710846,"eighty":-8.771001,"marketCap":807531900},{"date":"2026-04-10","current":-14.983685,"twenty":-12.570606,"median":-9.775997,"eighty":-8.798761,"marketCap":1031926357},{"date":"2026-04-17","current":-14.000462,"twenty":-13.015147,"median":-9.975459,"eighty":-8.828576,"marketCap":964211818},{"date":"2026-04-24","current":-13.514081,"twenty":-13.425068,"median":-10.075701,"eighty":-8.877926,"marketCap":930714732},{"date":"2026-05-01","current":-12.44718,"twenty":-13.370677,"median":-10.26642,"eighty":-8.898489,"marketCap":857237253},{"date":"2026-05-08","current":-11.767292,"twenty":-13.351187,"median":-10.76455,"eighty":-8.934568,"marketCap":810413370},{"date":"2026-05-15","current":-10.76944,"twenty":-13.300701,"median":-10.81684,"eighty":-8.966981,"marketCap":818337411},{"date":"2026-05-22","current":-11.162865,"twenty":-13.208546,"median":-10.76944,"eighty":-8.989273,"marketCap":848232660},{"date":"2026-05-29","current":-11.058584,"twenty":-13.135327,"median":-10.864241,"eighty":-9.002829,"marketCap":840308618},{"date":"2026-06-05","current":-9.807205,"twenty":-13.084182,"median":-10.80499,"eighty":-9.017037,"marketCap":745220116},{"date":"2026-06-12","current":-9.807205,"twenty":-13.030837,"median":-10.755219,"eighty":-9.036643,"marketCap":745220116},{"date":"2026-06-18","current":-9.788245,"twenty":-12.946112,"median":-10.53322,"eighty":-9.042258,"marketCap":743779381},{"date":"2026-06-26","current":-11.43779,"twenty":-12.867664,"median":-10.624868,"eighty":-9.042428,"marketCap":869123316},{"date":"2026-07-02","current":-6.07677,"twenty":-12.855112,"median":-10.547048,"eighty":-9.032928,"marketCap":461755529},{"date":"2026-07-10","current":-6.403835,"twenty":-12.813273,"median":-10.376014,"eighty":-8.958621,"marketCap":486608205},{"date":"2026-07-17","current":-5.550622,"twenty":-12.635456,"median":-10.177718,"eighty":-8.800817,"marketCap":421775136},{"date":"2026-07-24","current":-5.36576,"twenty":-12.598847,"median":-10.075701,"eighty":-8.689259,"marketCap":407727971},{"date":"2026-07-31","current":-5.37998,"twenty":-12.561192,"median":-10.06542,"eighty":-8.56425,"marketCap":408808522},{"date":"2026-08-07","current":-5.090694,"twenty":-12.489019,"median":-9.881902,"eighty":-8.43493,"marketCap":481925817},{"date":"2026-08-14","current":-5.393903,"twenty":-12.464961,"median":-9.807205,"eighty":-8.177768,"marketCap":510630029},{"date":"2026-08-21","current":-5.202222,"twenty":-12.450318,"median":-9.782121,"eighty":-7.430686,"marketCap":492483973},{"date":"2026-08-28","current":-5.16772,"twenty":-12.413708,"median":-9.712404,"eighty":-6.987812,"marketCap":489217683},{"date":"2026-09-04","current":-4.600344,"twenty":-12.384421,"median":-9.710846,"eighty":-6.276801,"marketCap":435505356},{"date":"2026-09-11","current":-4.048303,"twenty":-12.366639,"median":-9.695292,"eighty":-6.160195,"marketCap":383244713},{"date":"2026-09-18","current":-3.592102,"twenty":-12.358271,"median":-9.618094,"eighty":-5.832183,"marketCap":340057098},{"date":"2026-09-25","current":-3.373586,"twenty":-12.336306,"median":-9.537021,"eighty":-5.714629,"marketCap":319370594},{"date":"2026-10-01","current":-3.16657,"twenty":-12.303359,"median":-9.479385,"eighty":-5.516493,"marketCap":299772853}],"updateTime":1790979960343},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"EVMN\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2672457769","title":"US Stocks on the MOVE-Cardinal Health, nVent, Acuity","url":"https://stock-news.laohu8.com/highlight/detail?id=2672457769","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672457769?lang=en_us&edition=fundamental","pubTime":"2026-10-02 02:00","pubTimestamp":1790877639,"startTime":"0","endTime":"0","summary":"BUZZ-US STOCKS ON THE MOVE-Cardinal Health, nVent, AcuityOct 1 (Reuters)-The S&P 500 fell to a two-week low on Thursday as a global bond selloff, fueled by higher oil prices and inflation concerns, pu","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nL4N45N1BS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NNE","AYI","NESR","TOL","FTEC","ELV","VERI","NU","VICR","KDP","CVS","IETC","SHAZ","ACCV","PRGS","IMNM","VPU","EVMN","MKC","ILDR","IBM","UNH","CEPL","PHM","MU","RDW","ABAT","FCOM","FRVO","LEN","RTH","SNPS","DHI","GOOGL","ACN","GOOP","CAH","BJRI","TMED","GRND","GOOY","RXL","CEG","AAPL","HUM","CTSH","RKLB","FHTX","ORA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672752636","title":"Evommune Gains After Eczema Drug Meets Mid-Stage Trial Goal","url":"https://stock-news.laohu8.com/highlight/detail?id=2672752636","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672752636?lang=en_us&edition=fundamental","pubTime":"2026-10-01 20:19","pubTimestamp":1790857151,"startTime":"0","endTime":"0","summary":"BUZZ-Evommune gains after eczema drug meets mid-stage trial goal** Shares of drug developer EvommuneEVMN.Nrise 4.9% to $8.67 premarket** Co says its experimental injectable drug EVO301 met the main goal of a mid-stage trial involving 70 adults with moderate-to-severe atopic dermatitis, commonly known as eczema** Says patients treated with EVO301 had a 55% average reduction in the severity and extent of eczema after 12 weeks, compared with 22% for those given placebo** About 29% of EVO301 patients achieved at least a 75% improvement in eczema severity versus 9% on placebo** Drug was given twice during the trial, at the start and after four weeks; effects continued to improve for eight weeks after the final dose** Treatment-related side effects were reported in 10.4% of EVO301 patients versus 13.6% on placebo; no treatment-related serious or severe side effects were reported** As of last close, EVMN down 51.8% YTD","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nL4N45N0U5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EVMN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672752683","title":"Evommune presents Phase 2a PoC data on EVO301 at EADV Congress","url":"https://stock-news.laohu8.com/highlight/detail?id=2672752683","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672752683?lang=en_us&edition=fundamental","pubTime":"2026-10-01 20:15","pubTimestamp":1790856933,"startTime":"0","endTime":"0","summary":"Evommune (EVMN) shared additional data from its Phase 2a proof-of-concept trial of EVO301 in adults with moderate-to-severe atopic dermatitis durin...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/evommune-presents-phase-2a-poc-data-on-evo301-at-eadv-congress-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/evommune-presents-phase-2a-poc-data-on-evo301-at-eadv-congress-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","EVMN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672754276","title":"Evommune Says Phase 2a Trial Shows Evo301 Cuts EASI 55% at Week 12 in Atopic Dermatitis","url":"https://stock-news.laohu8.com/highlight/detail?id=2672754276","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672754276?lang=en_us&edition=fundamental","pubTime":"2026-10-01 20:01","pubTimestamp":1790856085,"startTime":"0","endTime":"0","summary":"Evommune says Phase 2a trial shows EVO301 cuts EASI 55% at Week 12 in atopic dermatitisEvommune presented additional Phase 2a proof-of-concept data for EVO301 in moderate-to-severe atopic dermatitis a","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nNDL2mzsYz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","EVMN"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":27,"pageCount":1,"totalSize":106,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/EVMN\",params:#limit:6,delay:false,,,undefined,":[]}}